5分钟阅读时间 | by Dennis Sandkühler博士 基本上,在GxP环境中对计算机化系统的使用需要考虑各项法规要求。 始终应该依照患者安全、产品质量、数据完整性以及合规要求方面各项潜在风险的背景来加以考虑。除了特定流程,如研发、生产和包装的各项要求之外,关于计算机化系统使用的一般要求(数据的电子存储要求)和验证流程(关于验证文件记录的要求)也必须被满足。 因此在考虑这些要求的时候,存在着可以区分开来的三种主要类型的要求: 1. 关于流程的具体要求
2. 关于计算机化系统的一般要求
图1 Figure 1 通过相关文件对工艺、计算机化系统和验证法规要求的分类 在数字化过程中必须实施计算机化系统的各项要求。在制药公司中,关于验证流程的法规要求必须纳入规程中。 作者Dennis Sandkühler博士 原文如下: Regulatory Requirements for Computerised Systems5 min. reading time | by Dennis Sandkühler, PhD Fundamentally, the use of computerised systems in GxP environments requires a consideration of regulatory requirements. This consideration should always be undertaken against the background of potential risks in terms of patient safety, product quality, data integrity and compliance requirements. In addition to the requirements for specific processes such as development, production and packaging, general requirements for the use of computerised system (requirement for electronic storage of data) and the validation process (requirement for validation documentation) must also be met. In a consideration of these requirements, there are therefore three main types of requirements that can be distinguished: 1. Specific requirements for the process
2. General requirements for computerised systems
3. Requirements for the validation of computerised systems
These different regulatory requirements find their way into various documents, as shown in Figure 1. Figure 1 Division of the regulatory requirements for processes, computerised systems and validation with the associated documents Requirements for computerised systems must be implemented for the digitised processes. In a pharmaceutical company, the regulatory requirements for the validation process must be incorporated into a procedural instruction. AuthorQuality Management Representative at d.velop Digital Life Sciences GmbH E-Mail: dennis.sandkuehler@dvelop-ls.de |
|